Company Intelligence

Caresyntax

Caresyntax provides enterprise-grade artificial intelligence solutions, delivering specialized Caresyntax Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Boston, United States
Founded
2013
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

Caresyntax is a Healthcare AI company based in Boston, United States, founded in 2013.

Boston surgical intelligence platform ingesting OR video, device, and outcomes data to improve precision surgery with AI analytics.

Verified founder profiles on Brel: Dennis Kogan, Bjoern von Siemens.

What it does

Through the deployment of Caresyntax Platform, Caresyntax provides computational automation and data intelligence for organizations operating in Artificial Intelligence.

What it builds

Caresyntax Platform

Why It Matters

Caresyntax provides enterprise-grade artificial intelligence solutions, delivering specialized Caresyntax Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Funding

Verified funding disclosures on file for this company.

  • August 15, 2024: Caresyntax raised $180 million through Series C extension and growth debt.

Products

Products and platforms connected to this company.

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Caresyntax

Industry

Industries served

  • Healthcare Technology

Capabilities

Caresyntax applies AI to surgical video, audio, and structured OR data for analytics spanning quality, efficiency, safety, and predictive clinical decision support…

Features

Vendor-neutral precision surgery platform capturing video, audio, device, EMR, and outcomes data across the surgical continuum, with AI analytics, edge-to-cloud applications, and…

Deployment

The 2024 financing validates investor belief that precision surgery platforms can monetize both health-system SaaS and medtech real-world evidence.

Country

United States

Use cases

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • July 16, 2025: Matt Krueger elevated to Chief Executive Officer, succeeding co-founders Kogan and von Siemens in operating leadership. Latest
  • Company founded 2013 · founded Source
  • Development 2013 · development Source
  • Funding 2024 · funding Source
  • Leadership 2025 · leadership Source

Frequently Asked Questions

What does Caresyntax do?

Caresyntax specializes in artificial intelligence, developing Caresyntax Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Caresyntax based and when was it founded?

Caresyntax is based in United States and was founded in 2013.

What are the main products offered by Caresyntax?

The flagship platform from Caresyntax is Caresyntax Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Caresyntax?

Caresyntax primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.